Sign In | Join Free | My
Wuhan uni-pharma bio-tech co.,ltd
Wuhan Uni-pharma Bio-tech Co.,Ltd
Home > Injection Medicine >

Organic Chemcials Triamcinolone Acetonide Injection Medicine 80mg / 2ml Ceramic White Word , Brown

Wuhan uni-pharma bio-tech co.,ltd
Wuhan uni-pharma bio-tech co.,ltd
Province/State: Hubei
Country/Region: China
Tel: 86-27-82316816

Organic Chemcials Triamcinolone Acetonide Injection Medicine 80mg / 2ml Ceramic White Word , Brown

Model Number : 80mg/2ml
Place of Origin : China
MOQ : 20,000,000Amps
Payment Terms : L/C, D/P, T/T
Delivery Time : After packaging confirmed 30 days
Packaging Details : 5 ampoules/box*400 boxes/ctn
Brand Name : Uni-pharma
Certification : GMP
Price : USD 2.10/Box
Applications : Internal Medicine
Usage method : Injectable
Applicable people : Adults
Form : Liquid
Shape : Injection
Type : Organic Chemcials
Pharmaceutical methods : Chemical Synthesis
Specification : 80mg/2ml
Contact Now

Western Medicine TRIAMCINOLONE ACETONIDE INJECTION 80mg/2ml (Ampoule , Box of 5 amps 2m , Ceramic white word , Brown)


Triamcinolone acetonide injectable suspension is indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids, and for visualization during vitrectomy.1


Triamcinolone acetonide injectable suspension is a corticosteroid that has seen “off-label” intravitreal use for a variety of ophthalmic uses, when topical or systemic therapy is ineffective or undesirable. Toxicity has been observed, however, in several in vitro and in vivo models. It is not clear if it is the drug, the benzyl alcohol–containing vehicle, or some combination of the two that is responsible for the toxicity. It has been hypothesized that the alcoholic vehicle may exert a predominant or potentiating effect of the triamcinolone toxicity.4,5 Triamcinolone acetonide injectable suspension is the first benzyl alcohol–free triamcinolone suspension to receive Food and Drug Administration (FDA) approval, and is the only triamcinolone formulation labeled for intravitreal injection.1


The aqueous humor pharmacokinetics of triamcinolone have been assessed following a single triamcinolone acetonide 4 mg intravitreal dose in 5 subjects. Peak aqueous humor concentration of triamcinolone ranged from 2,150 to 7,202 ng/mL, half-life ranged from 76 to 635 hours, and the area under the curve ranged from 231 to 1,911 ng•h/mL. The mean elimination half-life was 18.7 days in 4 nonvitrectomized eyes and 3.2 days in the 1 patient who had undergone vitrectomy.1


The most common adverse reactions following administration of triamcinolone acetonide were elevated intraocular pressure and cataract progression. These reactions occurred in 20% to 60% of patients.1 Less common reactions that occurred in up to 2% of patients included endophthalmitis, hypopyon, injection-site reactions (blurring, transient discomfort), glaucoma, vitreous floaters, detachment of retinal pigment epithelium, optic disc vascular disorder, eye inflammation, conjunctival hemorrhage, and reduced visual acuity.1


Live or live attenuated vaccines should not be administered to patients receiving immunosuppressive doses of corticosteroids.1 Corticosteroids may increase blood glucose. An increased risk of GI adverse reactions is possible if corticosteroids are administered in conjunction with nonsteroidal anti-inflammatory drugs or salicylates.1 Corticosteroids may enhance or diminish anticoagulant effects. Interactions have also been reported between systemic corticosteroids and amphotericin B, anticholinesterase agents, isoniazid, CYP3A4 inducers (barbiturates, carbamazepine, phenytoin, rifampin), CYP3A4 inhibitors (ketoconazole, macrolide antibiotics), cholestyramine, cyclosporine, digitalis, estrogens, and potassium-depleting agents.1 Corticosteroids may also suppress reactions to skin tests.1


The recommended initial dose for all indication except visualization is 4 mg (100 mcL of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment.1 The recommended dose for visualization is 1 to 4 mg (25 to 100 mcL of 40 mg/mL suspension) administered intravitreally.1


Triamcinolone acetonide suspension should be stored between 4° and 25°C (39° and 77°F) and protected from light and freezing.

Name of Drug:Triamcinolone Acetonide 80mg/2ml
Analytical results:According to the BP2014
CharacteristicsA white suspension which settles on standing but readily disperses on shaking.Conforms
IdentificationShould pass for the prescribed testPositive
Clarity and color of the solutionMeet the requirementConforms
Related substance

Single maximum impurity≤0.5%

Various impurities≤1.5%
Bacterial entodoxinsMeet the requirementConforms
Heavy metalsMeet the requirementConforms
Volume in containerMeet the requirementConforms
Visible particlesMeet the requirementConforms
SterilityMeet the requirementConforms

Contains Triamcinolone Acetonide (C24H31FO6)

Should be 90.0%~110.0% of the stated amount

Conclusion:The product complies with the requirements of BP2014

Product Tags:

Injectable drugs


injectable medicines

China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

Organic Chemcials Triamcinolone Acetonide Injection Medicine 80mg / 2ml Ceramic White Word , Brown Images

Inquiry Cart 0
Send your message to this supplier
Enter your email please.
To: Wuhan uni-pharma bio-tech co.,ltd
Characters Remaining: (0/3000)
Inquiry Cart 0